BioMarin Pharmaceutical Inc. buy Stifel Nicolaus
Start price
06.08.24
/
50%
€79.46
Target price
06.08.25
€102.66
Performance (%)
-3.17%
Price
11.09.24
€76.94
Summary
This prediction is currently active. With a performance of -3.17%, the BUY prediction for BioMarin Pharmaceutical Inc. by Stifel_Nicolaus is down slightly. This prediction currently runs until 06.08.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
BioMarin Pharmaceutical Inc. | -5.176% | -5.176% |
iShares Core DAX® | -0.168% | 4.802% |
iShares Nasdaq 100 | 2.946% | 3.520% |
iShares Nikkei 225® | 1.319% | 6.746% |
iShares S&P 500 | 2.044% | 3.551% |
Comments by Stifel_Nicolaus for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Stifel Nicolaus from $108.00 to $112.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.10
21.08.24
21.08.24
€103.11
21.08.25
21.08.25
-8.86%
11.09.24
11.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€86.10
21.12.23
21.12.23
€91.85
21.12.24
21.12.24
-10.64%
11.09.24
11.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€79.72
01.08.23
01.08.23
€98.41
01.08.24
01.08.24
-3.59%
02.08.24
02.08.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.17
28.02.23
28.02.23
€111.20
28.02.24
28.02.24
-13.41%
29.02.24
29.02.24